Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

A novel mouse model of HIV-1 disease.

Jolicoeur P, Kay DG, Cool M, Jothy S, Rebai N, Hanna Z.

Leukemia. 1999 Apr;13 Suppl 1:S78-80. No abstract available.

PMID:
10232371
2.

Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection.

Lorès P, Boucher V, Mackay C, Pla M, Von Boehmer H, Jami J, Barré-Sinoussi F, Weill JC.

AIDS Res Hum Retroviruses. 1992 Dec;8(12):2063-71.

PMID:
1493054
3.
5.
6.
7.

Transgenic mouse model of ethanol as a cofactor in HIV disease.

Prakash O, Joshi BH, Zhang P, Aw TY, Teng S, Ali M, Shellito JE, Nelson S.

Alcohol Clin Exp Res. 1998 Aug;22(5 Suppl):266S-268S. Review. No abstract available.

PMID:
9727649
8.

Functional human CD4 protein produced in milk of transgenic mice.

Yu SH, Deen KC, Lee E, Hennighausen L, Sweet RW, Rosenberg M, Westphal H.

Mol Biol Med. 1989 Aug;6(4):255-61.

PMID:
2482919
9.

Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.

Schüle S, Steidl S, Panitz S, Coulibaly C, Kalinke U, Cichutek K, Schweizer M.

Virology. 2006 Jul 20;351(1):237-47.

10.

Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Priceputu E, Hanna Z, Hu C, Simard MC, Vincent P, Wildum S, Schindler M, Kirchhoff F, Jolicoeur P.

J Virol. 2007 May;81(9):4677-93.

11.

Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes.

Benvenisty N, Ornitz DM, Bennett GL, Sahagan BG, Kuo A, Cardiff RD, Leder P.

Oncogene. 1992 Dec;7(12):2399-405.

PMID:
1461648
13.

Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.

Zhang JX, Diehl GE, Littman DR.

PLoS One. 2008 Apr 30;3(4):e2035. doi: 10.1371/journal.pone.0002035.

14.

Transgenic models of HIV-1.

Klotman PE, Rappaport J, Ray P, Kopp JB, Franks R, Bruggeman LA, Notkins AL.

AIDS. 1995 Apr;9(4):313-24. Review.

PMID:
7794536
15.

Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.

Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y, Dewan MZ, Yu Z, Ito M, Morio T, Shimizu N, Honda M, Yamamoto N.

Blood. 2007 Jan 1;109(1):212-8.

16.

A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christoph G, Manci E, Culberson D, Factor SM, Nagel RL.

Blood. 1995 Sep 15;86(6):2419-28.

17.

Immunopathogenesis of HIV infection.

Fauci AS.

J Acquir Immune Defic Syndr. 1993 Jun;6(6):655-62. Review. No abstract available.

PMID:
8098755
18.

HIV-1 infection in the lymphoid organs.

Graziosi C, Pantaleo G, Demarest JF, Cohen OJ, Vaccarezza M, Butini L, Montroni M, Fauci AS.

AIDS. 1993 Nov;7 Suppl 2:S53-8. Review.

PMID:
8161447
19.

A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses.

Laub R, Dorsch M, Meyer D, Ermann J, Hedrich HJ, Emmrich F.

J Immunol Methods. 2000 Dec 1;246(1-2):37-50.

PMID:
11121545
20.

M cells as portals of entry for HIV.

Owen RL.

Pathobiology. 1998;66(3-4):141-4.

PMID:
9693315
Items per page

Supplemental Content

Support Center